12:00 AM
 | 
May 11, 2009
 |  BC Week In Review  |  Company News  |  Deals

Seattle Life Sciences, ZymoGenetics deal

ZymoGenetics granted Seattle Life Sciences exclusive, worldwide rights to eight preclinical programs outside of ZymoGenetics' core focus of immunology. Seattle Life Sciences, a newco formed specifically to develop ZymoGenetics' preclinical portfolio,...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >